← All stories
Markets
STAT+: Skylar Bio kicks off new gene therapy trial for deafness
Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.
Covered by 1 outlet
All coverage · 1 article